The SIERRA trial may enable bone marrow transplant even if your AML is not in remissionLearn More About the Sierra Trial
Transplant Can Be an Option for Patients With Active, Relapsed or Refractory Acute Myeloid LeukemiaLearn More About the Sierra Trial
Do I Qualify?
I have AML. Am I eligible for the SIERRA study?
Find a SIERRA clinical trial site near you
Answers to common questions about SIERRA trial
Targeting Acute Myeloid Leukemia
The SIERRA Trial is investigating the use of 131 I apamistamab (Iomab-B) in patients age 55 and older with active, relapsed or refractory Acute Myeloid Leukemia (AML)Learn More About SIERRA Trial
What Is It?
Learn More About 131I apamistamab
131 I apamistamab (Iomab-B) is an investigational drug that targets bone marrow and blood cancer (leukemia) cells. In this clinical trial, it is used to help relapsed or refractory AML patients get ready for bone marrow transplant (BMT)Learn More About Iomab-B